Serina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?

Insider buying vs selling

Have Serina Therapeutics Inc insiders been buying or selling?
Gregory BaileyDirector2024-05-305,205$9.50
Gregory BaileyDirector2024-05-291,173$9.50
Gregory BaileyDirector2024-05-289,019$9.50
Gregory BaileyDirector2024-05-232,371$9.50
Steven MintzDirector2024-05-216,651$10.00
Gregory BaileyDirector2024-05-211,422$9.50
Gregory BaileyDirector2024-05-21916$9.50
Steven MintzDirector2024-05-212,500$9.75
Steven MintzDirector2024-05-201,240$9.42
Steven MintzDirector2024-05-201,240$9.44

1 of 2

SER insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SER insiders and whales buy or sell their stock.

SER Shareholders

What type of owners hold Serina Therapeutics Inc stock?
Juvenescence Us Corp195.48%16,447,500$135.53MInsider
Juvenescence Ltd195.48%16,447,500$135.53MInsider
Steven A. Ledger2.71%227,927$1.88MInsider
John F. Mauldin1.49%125,000$1.03MInsider
Broadwood Capital Inc1.01%85,219$702.20kInstitution
Tacey Viegas0.70%58,610$482.95kInsider
Judith Segall0.63%52,624$433.62kInsider
Michael D. West0.50%41,982$345.93kInsider
Donnis L. Casey0.28%23,725$195.49kInsider
Gregory Bailey0.24%20,206$166.50kInsider

1 of 3

SER vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SER0.33%99.67%Net BuyingNet Buying
CVM13.82%40.64%Net BuyingNet Buying
MAIA3.03%20.26%Net BuyingNet Buying
VANI4.37%95.63%Net Buying

Serina Therapeutics Stock Ownership FAQ

Who owns Serina Therapeutics?

Serina Therapeutics (NYSEMKT: SER) is owned by 1.31% institutional shareholders, 397.83% Serina Therapeutics insiders, and 0.00% retail investors. Juvenescence Us Corp is the largest individual Serina Therapeutics shareholder, owning 16.45M shares representing 195.48% of the company. Juvenescence Us Corp's Serina Therapeutics shares are currently valued at $135.53M.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.